Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia.

Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T.

Neuropsychiatr Dis Treat. 2019 Jan 21;15:293-301. doi: 10.2147/NDT.S190381. eCollection 2019.

2.

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis.

Numata S, Umehara H, Ohmori T, Hashimoto R.

Front Pharmacol. 2018 Sep 26;9:1049. doi: 10.3389/fphar.2018.01049. eCollection 2018. Review.

3.

Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Tomioka Y, Numata S, Kinoshita M, Umehara H, Watanabe SY, Nakataki M, Iwayama Y, Toyota T, Ikeda M, Yamamori H, Shimodera S, Tajima A, Hashimoto R, Iwata N, Yoshikawa T, Ohmori T.

J Psychiatry Neurosci. 2018 May;43(3):194-200.

4.

Elevated peripheral blood glutamate levels in major depressive disorder.

Inoshita M, Umehara H, Watanabe SY, Nakataki M, Kinoshita M, Tomioka Y, Tajima A, Numata S, Ohmori T.

Neuropsychiatr Dis Treat. 2018 Apr 6;14:945-953. doi: 10.2147/NDT.S159855. eCollection 2018.

5.

Retraction: A significant causal association between C-reactive protein levels and schizophrenia.

Inoshita M, Numata S, Tajima A, Kinoshita M, Umehara H, Nakataki M, Ikeda M, Maruyama S, Yamamori H, Kanazawa T, Shimodera S, Hashimoto R, Imoto I, Yoneda H, Iwata N, Ohmori T.

Sci Rep. 2018 Feb 21;8:46947. doi: 10.1038/srep46947.

6.

Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Tomioka Y, Numata S, Kinoshita M, Umehara H, Watanabe SY, Nakataki M, Iwayama Y, Toyota T, Ikeda M, Yamamori H, Shimodera S, Tajima A, Hashimoto R, Iwata N, Yoshikawa T, Ohmori T.

J Psychiatry Neurosci. 2018 Feb 2;43(2):170053. doi: 10.1503/jpn.170053. [Epub ahead of print]

7.

Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder.

Umehara H, Numata S, Watanabe SY, Hatakeyama Y, Kinoshita M, Tomioka Y, Nakahara K, Nikawa T, Ohmori T.

Sci Rep. 2017 Jul 7;7(1):4855. doi: 10.1038/s41598-017-05121-6.

8.

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia.

Kinoshita M, Numata S, Tajima A, Yamamori H, Yasuda Y, Fujimoto M, Watanabe S, Umehara H, Shimodera S, Nakazawa T, Kikuchi M, Nakaya A, Hashimoto H, Imoto I, Hashimoto R, Ohmori T.

Int J Mol Sci. 2017 Mar 14;18(3). pii: E632. doi: 10.3390/ijms18030632.

9.

Gene expression-based biological test for major depressive disorder: an advanced study.

Watanabe SY, Numata S, Iga JI, Kinoshita M, Umehara H, Ishii K, Ohmori T.

Neuropsychiatr Dis Treat. 2017 Feb 21;13:535-541. doi: 10.2147/NDT.S120038. eCollection 2017.

10.

Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.

Kinoshita M, Numata S, Tajima A, Nishi A, Muraki S, Tsuchiya A, Umehara H, Watanabe SY, Imoto I, Ohmori T.

Psychiatry Res. 2016 Dec 30;246:833-837. doi: 10.1016/j.psychres.2016.10.017. Epub 2016 Oct 17.

PMID:
27810229
11.

1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder.

Kubo H, Nakataki M, Sumitani S, Iga JI, Numata S, Kameoka N, Watanabe SY, Umehara H, Kinoshita M, Inoshita M, Tamaru M, Ohta M, Nakayama-Yamauchi C, Funakoshi Y, Harada M, Ohmori T.

J Affect Disord. 2017 Jan 15;208:139-144. doi: 10.1016/j.jad.2016.08.046. Epub 2016 Oct 8.

PMID:
27770643
12.

Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.

Umehara H, Numata S, Tajima A, Nishi A, Nakataki M, Imoto I, Sumitani S, Ohmori T.

PLoS One. 2016 Jun 9;11(6):e0157232. doi: 10.1371/journal.pone.0157232. eCollection 2016.

13.

A significant causal association between C-reactive protein levels and schizophrenia.

Inoshita M, Numata S, Tajima A, Kinoshita M, Umehara H, Nakataki M, Ikeda M, Maruyama S, Yamamori H, Kanazawa T, Shimodera S, Hashimoto R, Imoto I, Yoneda H, Iwata N, Ohmori T.

Sci Rep. 2016 May 19;6:26105. doi: 10.1038/srep26105. Retraction in: Sci Rep. 2018 Feb 21;8:46947.

14.

No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population.

Umehara H, Numata S, Kinoshita M, Watanabe S, Nakaaki S, Sumitani S, Ohmori T.

Neuropsychiatr Dis Treat. 2016 Mar 11;12:611-5. doi: 10.2147/NDT.S102100. eCollection 2016.

15.

Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder.

Iga J, Watanabe SY, Numata S, Umehara H, Nishi A, Kinoshita M, Inoshita M, Shimodera S, Fujita H, Ohmori T.

Hum Psychopharmacol. 2016 May;31(3):193-9. doi: 10.1002/hup.2527. Epub 2016 Mar 23.

PMID:
27005686
16.

Sex differences of leukocytes DNA methylation adjusted for estimated cellular proportions.

Inoshita M, Numata S, Tajima A, Kinoshita M, Umehara H, Yamamori H, Hashimoto R, Imoto I, Ohmori T.

Biol Sex Differ. 2015 Jun 25;6:11. doi: 10.1186/s13293-015-0029-7. eCollection 2015.

17.

No association between the COMT Val158Met polymorphism and the long-term clinical response in obsessive-compulsive disorder in the Japanese population.

Umehara H, Numata S, Tajima A, Kinoshita M, Nakaaki S, Imoto I, Sumitani S, Ohmori T.

Hum Psychopharmacol. 2015 Sep;30(5):372-6. doi: 10.1002/hup.2485. Epub 2015 May 26.

PMID:
26010653
18.

Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese population.

Watanabe SY, Iga J, Numata S, Umehara H, Nishi A, Kinoshita M, Inoshita M, Ohmori T.

J Affect Disord. 2015 Sep 1;183:156-8. doi: 10.1016/j.jad.2015.05.009. Epub 2015 May 15.

PMID:
26005777
19.

Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validation.

Numata S, Ishii K, Tajima A, Iga J, Kinoshita M, Watanabe S, Umehara H, Fuchikami M, Okada S, Boku S, Hishimoto A, Shimodera S, Imoto I, Morinobu S, Ohmori T.

Epigenetics. 2015;10(2):135-41. doi: 10.1080/15592294.2014.1003743. Epub 2015 Jan 14.

20.

Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection.

Umehara H, Iga J, Ohmori T.

Clin Psychopharmacol Neurosci. 2014 Apr;12(1):65-6. doi: 10.9758/cpn.2014.12.1.65. Epub 2014 Apr 24.

Supplemental Content

Loading ...
Support Center